Robotic Rehabilitation and Assistive Technologies Market Share

  • Report ID: 4581
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Robotic Rehabilitation And Assistive Technologies Industry - Regional Synopsis

North American Market Forecast   

 North America industry is expected to dominate majority revenue share of 37% by 2037, attributed to rising chronic disease prevalence coupled escalating geriatric population, and a strong healthcare industry.The growth of the market can be attributed majorly to the rising chronic disease prevalence coupled escalating geriatric population, and a strong healthcare industry is expected to drive the growth of the market in North America during the forecast period. For instance, the U.S. has more than 54 million adults aged 65 and older, or roughly 16.5% of the population in 2022, according to the U.S.  Census Bureau. Apart from that higher prevalence of cardiovascular diseases (CVDs) in the region, backed by the growth in robotic rehabilitation and assistive technologies owing to the ongoing development of robotics in North America, is projected to enlarge the market’s size during the forecast period. As of 2019, nearly 40% of the population in the USA was diagnosed with cardiovascular diseases and approximately 6 million people lost their lives owing to stroke in a similar year. Therefore, all these factors are expected to drive the growth of the market in the region during the forecast period.

Robotic Rehabilitation and Assistive Technologies S.

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of robotic rehabilitation and assistive technologies is evaluated at USD 3.19 billion.

The robotic rehabilitation and assistive technologies market size was valued at USD 2.59 billion in 2024 and is set to exceed USD 13.75 billion by 2037, expanding at over 13.7% CAGR during the forecast period i.e., between 2025-2037. Increasing incidence of orthopedic illnesses will drive the market growth.

North America industry is expected to dominate majority revenue share of 37% by 2037, attributed to rising chronic disease prevalence coupled escalating geriatric population, and a strong healthcare industry.

The major players in the market are AlterG, Inc., Bionik Laboratories Corp., Ekso Bionics Holdings, Inc., Vincent Medical Holdings Limited, Hocoma AG, CYBERDYNE Inc., Kinova inc., Rex Bionics Ltd, Instead Technologies Ltd.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos